## Abstract A realβtime PCR assay was developed for quantitative detection of B19 DNA in clinical serum samples. The assay was carried out using a LightCycler instrument and product formation was monitored continuously with the fluorescent doubleβstranded DNA binding dye SYBR Green I. With an optim
laboratory diagnosis of parvovirus B19 infection
β Scribed by J. Sanders Sevall; Judith Ritenhous; J. B. Peter
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 435 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0887-8013
No coin nor oath required. For personal study only.
β¦ Synopsis
The sensitivity and application of the polymerase chain reaction (PCR) for the diagnosis of parvovirus B19 (B19) infection was investigated by simultaneously assaying a collection of 279 consecutively received Samples for presence of anti-B19 IgM and IgG antibodies by Western blot and for B19 DNA by PCR and dot-blot hybridization (dot-blot); samples were sera from patients with suspected B19 infection. PCR and dot-blot detected B19 DNA in 9% (16/179) and 1%
(2/179), respectively of Ab-positive samples (IgM +/IgG -,IgM + IgG + ,lgM -IgG +),and in 28% (1 5/54) and 2% (1 /54), respectively, of IgM + samples. PCR also detected B19 DNA in 2% (2/100) of IgM -/IgGsamples, both of which had normal total IgG and IgM levels. PCR is of unique value because it permits diagnosis of B19 infection even in the absence of specific acute phase (IgM) and in the presence or absence of convalescentphase (IgG) Ab. o 1992Wiley-Liss, Inc.
π SIMILAR VOLUMES
## Abstract Since its discovery, human parvovirus B19 has been linked with a broad spectrum of clinical syndromes. An aetiological role for the virus has been confirmed in erythema infectiosum, transient aplastic crisis, persistent infection manifesting as pure red cell aplasia in immunocompromised
Background and Procedure. The frequency and clinical importance of parvovirus B19 infection were studied in children investigated or treated for various malignancies and cytopenias. Results. B19 infection was thus demonstrated in six out of 53 unselected children with malignancies by bone marrow exa
We present a case of parvovirus B19 infection in the first trimester, confirmed by polymerase chain reaction (PCR) in amniotic fluid and cord blood, that caused myocarditis, severe intrauterine growth retardation, and probably glomerulonephritis. Eventually a small-for-dates neonate was born, withou
To standardize a PCR assay for the detection of parvovirus B19 DNA in serum samples three different sample treatments were evaluated on the basis of the efficiency of recovery, reproducibility, convenience of sample handling, and presence of PCR inhibitors. Moreover, the presence of an internal stan